Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117933633 | 11793363 | 3 | F | 20151105 | 20160714 | 20151202 | 20160719 | EXP | CA-AMGEN-CANSP2015122995 | AMGEN | 47.00 | YR | A | F | Y | 0.00000 | 20160719 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117933633 | 11793363 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | 5900 | MG | 103795 | 50 | MG | UNKNOWN FORMULATION | /wk | ||||
| 117933633 | 11793363 | 2 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 117933633 | 11793363 | 3 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 117933633 | 11793363 | 4 | SS | CODEINE | CODEINE | 1 | Unknown | UNK | 0 | ||||||||||
| 117933633 | 11793363 | 5 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | 750 MG, QMO | 57750 | MG | 0 | 750 | MG | /month | |||||
| 117933633 | 11793363 | 6 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | 2 G, QD | 0 | 2 | G | QD | |||||||
| 117933633 | 11793363 | 7 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK UNK, QWK | 0 | /wk | |||||||||
| 117933633 | 11793363 | 8 | C | METHOTREXATE. | METHOTREXATE | 1 | 30 MG, QWK | 0 | 30 | MG | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117933633 | 11793363 | 1 | Rheumatoid arthritis |
| 117933633 | 11793363 | 2 | Rheumatoid arthritis |
| 117933633 | 11793363 | 3 | Product used for unknown indication |
| 117933633 | 11793363 | 4 | Product used for unknown indication |
| 117933633 | 11793363 | 5 | Rheumatoid arthritis |
| 117933633 | 11793363 | 6 | Rheumatoid arthritis |
| 117933633 | 11793363 | 7 | Rheumatoid arthritis |
| 117933633 | 11793363 | 8 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117933633 | 11793363 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117933633 | 11793363 | C-reactive protein abnormal | |
| 117933633 | 11793363 | Drug hypersensitivity | |
| 117933633 | 11793363 | Drug ineffective | |
| 117933633 | 11793363 | Nausea | |
| 117933633 | 11793363 | Pain in extremity | |
| 117933633 | 11793363 | Psoriasis | |
| 117933633 | 11793363 | Rash pruritic | |
| 117933633 | 11793363 | Red blood cell sedimentation rate abnormal | |
| 117933633 | 11793363 | Rheumatoid arthritis | |
| 117933633 | 11793363 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117933633 | 11793363 | 1 | 20061127 | 20090226 | 0 | |
| 117933633 | 11793363 | 2 | 2006 | 2006 | 0 | |
| 117933633 | 11793363 | 5 | 20090624 | 20151027 | 0 | |
| 117933633 | 11793363 | 6 | 2005 | 200803 | 0 | |
| 117933633 | 11793363 | 8 | 2005 | 0 |